{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:47:36Z","timestamp":1773391656315,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10552-025-02088-y","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T09:44:14Z","timestamp":1766569454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical value of serum biomarkers, magnetic resonance imaging risk scoring, and malignancy risk indices in distinguishing benign and malignant ovarian masses: an observational study"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5970-6935","authenticated-orcid":false,"given":"Naina","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishu","family":"Mangla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhrajyoti","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Setty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srujana","family":"Veldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja T.","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"4","key":"2088_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.18231\/j.ijpo.2020.112","volume":"7","author":"P Sharma","year":"2020","unstructured":"Sharma P, Rao PS, Mogra N, Talreja K (2020) Histopathological study of ovarian tumors in a tertiary healthcare centre of southern Rajasthan. Indian J Pathol Oncol 7(4):561\u2013566. https:\/\/doi.org\/10.18231\/j.ijpo.2020.112","journal-title":"Indian J Pathol Oncol"},{"key":"2088_CR2","doi-asserted-by":"publisher","unstructured":"Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno III DE, et al, On Behalf of NCD Global Health Research Group of Association of Pacific Rim Universities APRU (2022) Worldwide burden, risk factors, and temporal trends of ovarian cancer: a global study. Cancers (Basel) 14(9):2230. https:\/\/doi.org\/10.3390\/cancers14092230","DOI":"10.3390\/cancers14092230"},{"key":"2088_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/IJWH.S197604","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H (2019) Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health 11:287\u2013299. https:\/\/doi.org\/10.2147\/IJWH.S197604","journal-title":"Int J Womens Health"},{"issue":"1","key":"2088_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s13224-014-0575-7","volume":"65","author":"S Sharadha","year":"2015","unstructured":"Sharadha S, Sridevi TA, Renukadevi TK, Gowri R, Binayak D, Indra V (2015) Ovarian masses: changing clinico histopathological trends. J Obstet Gynaecol India 65(1):34\u201338. https:\/\/doi.org\/10.1007\/s13224-014-0575-7","journal-title":"J Obstet Gynaecol India"},{"issue":"11","key":"2088_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48534","volume":"15","author":"SA Sahu","year":"2023","unstructured":"Sahu SA, Shrivastava D (2023) A comprehensive review of screening methods for ovarian masses: towards earlier detection. Cureus 15(11):e48534. https:\/\/doi.org\/10.7759\/cureus.48534","journal-title":"Cureus"},{"issue":"22","key":"2088_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16223790","volume":"16","author":"G Spagnol","year":"2024","unstructured":"Spagnol G, Marchetti M, Carollo M, Bigardi S, Tripepi M, Facchetti E et al (2024) Clinical utility and diagnostic accuracy of ROMA, RMI, ADNEX, HE4, and CA125 in the prediction of malignancy in adnexal masses. Cancers (Basel) 16(22):3790. https:\/\/doi.org\/10.3390\/cancers16223790","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2088_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/uog.12323","volume":"41","author":"J Kaijser","year":"2013","unstructured":"Kaijser J, Bourne T, Valentin L, Sayasneh A, Van Holsbeke C, Vergote I et al (2013) Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies. Ultrasound Obstet Gynecol 41(1):9\u201320. https:\/\/doi.org\/10.1002\/uog.12323","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"2088_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1148\/radiol.204371","volume":"303","author":"EA Sadowski","year":"2022","unstructured":"Sadowski EA, Thomassin-Naggara I, Rockall A, Maturen KE, Forstner R, Jha P et al (2022) O-RADS MRI risk stratification system: guide for assessing adnexal lesions from the ACR O-RADS Committee. Radiology 303(1):35\u201347. https:\/\/doi.org\/10.1148\/radiol.204371","journal-title":"Radiology"},{"issue":"3","key":"2088_CR9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1148\/radiol.2018172271","volume":"287","author":"EA Sadowski","year":"2018","unstructured":"Sadowski EA, Paroder V, Patel-Lippmann K, Robbins JB, Barroilhet L, Maddox E et al (2018) Indeterminate adnexal cysts at US: prevalence and characteristics of ovarian cancer. Radiology 287(3):1041\u20131049. https:\/\/doi.org\/10.1148\/radiol.2018172271","journal-title":"Radiology"},{"issue":"6","key":"2088_CR10","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1007\/s00330-016-4600-3","volume":"27","author":"R Forstner","year":"2017","unstructured":"Forstner R, Thomassin-Naggara I, Cunha TM, Kinkel K, Masselli G, Kubik-Huch R et al (2017) ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol 27(6):2248\u20132257. https:\/\/doi.org\/10.1007\/s00330-016-4600-3","journal-title":"Eur Radiol"},{"issue":"12","key":"2088_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123730","volume":"12","author":"P Charkhchi","year":"2020","unstructured":"Charkhchi P, Cybulski C, Gronwald J, Wong FO, Narod SA, Akbari MR (2020) CA125 and ovarian cancer: a comprehensive review. Cancers (Basel) 12(12):3730. https:\/\/doi.org\/10.3390\/cancers12123730","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2088_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics7010012","volume":"7","author":"M Koshiyama","year":"2017","unstructured":"Koshiyama M, Matsumura N, Konishi I (2017) Subtypes of ovarian cancer and ovarian cancer screening. Diagnostics 7(1):12. https:\/\/doi.org\/10.3390\/diagnostics7010012","journal-title":"Diagnostics"},{"issue":"11","key":"2088_CR13","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1111\/jog.14427","volume":"46","author":"AA Lertkhachonsuk","year":"2020","unstructured":"Lertkhachonsuk AA, Buranawongtrakoon S, Lekskul N, Rermluk N, Wee-Stekly WW, Charakorn C (2020) Serum CA19-9, CA-125 and CEA as tumor markers for mucinous ovarian tumors. J Obstet Gynaecol Res 46(11):2287\u20132291. https:\/\/doi.org\/10.1111\/jog.14427","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"2088_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5005\/jp-journals-10054-0161","volume":"24","author":"A Radhakrishnan","year":"2020","unstructured":"Radhakrishnan A, Malukar N, Jain S (2020) Serum CA-125 and serum CEA ratio to distinguish between ovarian malignancies and non-ovarian malignancies. Indian J Med Biochem 24(3):96\u201398. https:\/\/doi.org\/10.5005\/jp-journals-10054-0161","journal-title":"Indian J Med Biochem"},{"issue":"10","key":"2088_CR15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","volume":"97","author":"I Jacobs","year":"1990","unstructured":"Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG (1990) A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. BJOG 97(10):922\u2013929. https:\/\/doi.org\/10.1111\/j.1471-0528.1990.tb02448.x","journal-title":"BJOG"},{"issue":"8","key":"2088_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1471-0528.1996.tb09882.x","volume":"103","author":"S Tingulstad","year":"1996","unstructured":"Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T et al (1996) Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. BJOG 103(8):826\u2013831. https:\/\/doi.org\/10.1111\/j.1471-0528.1996.tb09882.x","journal-title":"BJOG"},{"issue":"3","key":"2088_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/00006250-199903000-00028","volume":"93","author":"S Tingulstad","year":"1999","unstructured":"Tingulstad S, Hagen B, Skjeldestad FE, Halvorsen T, Nustad K, Onsrud M (1999) The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol 93(3):448\u2013452","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2088_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejogrb.2009.02.048","volume":"144","author":"Y Yamamoto","year":"2009","unstructured":"Yamamoto Y, Yamada R, Oguri H, Maeda N, Fukaya T (2009) Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses. Eur J Obstet Gynecol Reprod Biol 144(2):163\u2013167. https:\/\/doi.org\/10.1016\/j.ejogrb.2009.02.048","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"2088_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5005\/jp-journals-10006-1706","volume":"11","author":"NC Shekar","year":"2019","unstructured":"Shekar NC, Dasappa P, Rangaiah N, Nagothi NP (2019) Evaluation of risk of malignancy index 5\u2014a new indicator in differentiating benign and malignant ovarian masses. J South Asian Fed Obstet Gynaecol 11(4):258\u2013262. https:\/\/doi.org\/10.5005\/jp-journals-10006-1706","journal-title":"J South Asian Fed Obstet Gynaecol"},{"key":"2088_CR20","unstructured":"Kurman RJ, International Agency for Research on Cancer, World Health Organization (2014) WHO classification of tumours of female reproductive organs, 4th edn. International Agency for Research on Cancer, Lyon, p 307"},{"issue":"1","key":"2088_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J Prat","year":"2014","unstructured":"Prat J, FIGO Committee on Gynecologic Oncology (2014) Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 124(1):1\u20135. https:\/\/doi.org\/10.1016\/j.ijgo.2013.10.001","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"2088_CR22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.82415","volume":"17","author":"AK Singh","year":"2025","unstructured":"Singh AK, Yadav P, Shukla M, Samaiya S, Singh S, Sorout S (2025) Comparative meta-analysis of carbohydrate antigen 125 (CA-125), human epididymis protein 4 (HE4), and diagnostic indices (risk of malignancy index (RMI) and risk of ovarian malignancy algorithm (ROMA)) for pre-operative detection of ovarian carcinoma. Cureus 17(4):e82415. https:\/\/doi.org\/10.7759\/cureus.82415","journal-title":"Cureus"},{"issue":"4","key":"2088_CR23","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.7314\/apjcp.2016.17.4.2177","volume":"17","author":"S Ertas","year":"2016","unstructured":"Ertas S, Vural F, Vural F, Tufekci EC, Ertas AC, Kose G et al (2016) Predictive value of malignancy risk indices for ovarian masses in premenopausal and postmenopausal women. Asian Pac J Cancer Prev 17(4):2177\u20132183. https:\/\/doi.org\/10.7314\/apjcp.2016.17.4.2177","journal-title":"Asian Pac J Cancer Prev"},{"issue":"18","key":"2088_CR24","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.7314\/apjcp.2014.15.18.7793","volume":"15","author":"HS Simsek","year":"2014","unstructured":"Simsek HS, Tokmak A, Ozgu E, Doganay M, Danisman N, Erkaya S et al (2014) Role of a risk of malignancy index in clinical approaches to adnexal masses. Asian Pac J Cancer Prev 15(18):7793\u20137797. https:\/\/doi.org\/10.7314\/apjcp.2014.15.18.7793","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"2088_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000529355","volume":"88","author":"Z Vilendecic","year":"2023","unstructured":"Vilendecic Z, Radojevic M, Stefanovic K, Dotlic J, Likic Ladjevic I, Dugalic S et al (2023) Accuracy of IOTA simple rules, IOTA ADNEX model, RMI, and subjective assessment for preoperative adnexal mass evaluation: the experience of a tertiary care referral hospital. Gynecol Obstet Investig 88(2):116\u2013122. https:\/\/doi.org\/10.1159\/000529355","journal-title":"Gynecol Obstet Investig"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-025-02088-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T04:00:31Z","timestamp":1770609631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-025-02088-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2088"],"URL":"https:\/\/doi.org\/10.1007\/s10552-025-02088-y","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Ethical Committee (AIIMS\/BBN\/IEC\/July\/2023\/295).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study was conducted after informed written consent from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"3"}}